Stockscreener 앱 받기
2.58
0.77%
-0.02
시간 외 거래:
2.58
전일 마감가:
$2.60
열려 있는:
$2.65
하루 거래량:
60,594
Relative Volume:
1.02
시가총액:
$79.65M
수익:
$6.21M
순이익/손실:
$-19.92M
주가수익비율:
-2.4571
EPS:
-1.05
순현금흐름:
$-16.76M
1주 성능:
-0.77%
1개월 성능:
+0.78%
6개월 성능:
+8.18%
1년 성능:
+15.44%
1일 변동 폭
$2.51
$2.6882
1주일 범위
$2.40
$2.75
52주 변동 폭
$2.07
$3.798
InspireMD Inc. Stock (NSPR) Company Profile
명칭
InspireMD Inc.
전화
972 3 6917691
주소
4 Menorat Hamaor Street, Tel Aviv
NSPR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NSPR
InspireMD Inc.
|
2.58 | 79.65M | 6.21M | -19.92M | -16.76M | -1.05 |
|
ABT
Abbott Laboratories
|
131.99 | 230.70B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.87 | 154.22B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
388.08 | 145.74B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
85.81 | 107.03B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
74.80 | 44.06B | 5.54B | 4.18B | 623.10M | 7.00 |
InspireMD Inc. Stock (NSPR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2016-01-07 | 개시 | Rodman & Renshaw | Buy |
| 2015-03-13 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2013-11-26 | 개시 | Oppenheimer | Outperform |
InspireMD Inc. 주식(NSPR)의 최신 뉴스
Piper Sandler cuts InspireMD stock price target to $4.00 By Investing.com - Investing.com Nigeria
Piper Sandler cuts InspireMD stock price target to $4.00 - Investing.com Australia
InspireMD, Inc. (NASDAQ:NSPR) Q1 2025 Earnings Call Transcript - Insider Monkey
InspireMD Inc (NSPR) Q1 2025 Earnings Call Highlights: Revenue Growth Amid Operational Challenges By GuruFocus - Investing.com Canada
InspireMD Inc’s Earnings Call: Growth Amid Challenges - TipRanks
Earnings call transcript: InspireMD Q1 2025 shows mixed results - Investing.com
InspireMD Inc. Reports Q1 2025 Financial Results - TipRanks
InspireMD earnings beat by $0.09, revenue fell short of estimates - Investing.com Canada
InspireMD reports Q1 EPS (22c) vs (21c) last year - TipRanks
InspireMD (NSPR) Posts Slight Increase in Q1 Revenue | NSPR Stoc - GuruFocus
InspireMD Inc (NSPR) Q1 2025 Earnings: Revenue of $1.53M Beats E - GuruFocus
InspireMD outlines Q3 2025 FDA approval target for CGuard Prime - MSN
InspireMD Stock Dips On Wider-Than-Expected Q1 Loss, But Retail Is Optimistic - Asianet Newsable
InspireMD, Inc. (NSPR) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
InspireMD Reports First Quarter 2025 Financial Results - The Manila Times
InspireMD, Inc. Reports Q1 2025 Financial Results and Anticipates FDA Approval for CGuard™ Prime Carotid Stent System - Nasdaq
InspireMD Reports First Quarter 2025 Financial Results - GlobeNewswire Inc.
Renaissance Technologies LLC Invests $27,000 in InspireMD, Inc. (NYSE:NSPR) - Defense World
InspireMD Inc (NSPR) Q1 2025 Earnings Report Preview: What To Lo - GuruFocus
INSPIREMD Earnings Preview: Recent $NSPR Insider Trading, Hedge Fund Activity, and More - Nasdaq
InspireMD (NYSE:NSPR) Earns Sell Rating from Analysts at StockNews.com - Defense World
InspireMD to Present at Upcoming Bank of America 2025 Healthcare Conference - The Manila Times
InspireMD (NYSE:NSPR) Now Covered by Analysts at StockNews.com - Defense World
InspireMD to Announce First Quarter 2025 Financial Results - GlobeNewswire
InspireMD, Inc. to Announce First Quarter 2025 Financial Results on May 9, 2025 - Nasdaq
Destination Excellence: New Clinical Partnerships Inspire MD Students, Aid Community Organizations - Drexel
InspireMD Q1 2025 Earnings: Leading Carotid Stent Developer Reveals Financial Performance Date - Stock Titan
StockNews.com Begins Coverage on InspireMD (NYSE:NSPR) - Defense World
StockNews.com Initiates Coverage on InspireMD (NYSE:NSPR) - Defense World
InspireMD at 24th Annual Needham: Strategic Moves in Healthcare By Investing.com - Investing.com Canada
InspireMD announces inducement grants under Nasdaq listing rule - TipRanks
Inspiremd Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - marketscreener.com
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
InspireMD Expands Team: 299K Shares Granted to New Medical Device Experts - Stock Titan
InspireMD files $200M mixed securities shelf - MSN
InspireMD Inc Files For Mixed Shelf Of Up To $200 MillionSEC Filing - MarketScreener
InspireMD Files $200 Million Mixed Shelf - marketscreener.com
InspireMD (NYSE:NSPR) Coverage Initiated at StockNews.com - Defense World
InspireMD to Present at Upcoming 24th Annual Needham Virtual Healthcare Conference - The Manila Times
InspireMD CEO to Reveal Latest CGuard Strategy at Major Healthcare Conference - Stock Titan
InspireMD (NYSE:NSPR) & AngioDynamics (NASDAQ:ANGO) Head-To-Head Review - Defense World
Reviewing Anika Therapeutics (NASDAQ:ANIK) and InspireMD (NYSE:NSPR) - Defense World
InspireMD, Inc. (NSPR) Reports Q4 Loss, Tops Revenue Estimates - MSN
InspireMD, Inc. (NASDAQ:NSPR) Q4 2024 Earnings Call Transcript - Insider Monkey
InspireMD Inc (NSPR) Q4 2024 Earnings Call Highlights: Revenue Growth Amid Rising Expenses and ... By GuruFocus - Investing.com Canada
InspireMD Inc. Reports 2024 Financial Results and Strategic Progress - TipRanks
InspireMD’s Earnings Call: Cautious Optimism Amid Challenges - TipRanks
InspireMD earnings beat by $0.01, revenue topped estimates - Investing.com Canada
Earnings call transcript: InspireMD Q4 2024 beats revenue forecast, stock rises - Investing.com India
InspireMD Inc reports results for the quarter ended December 31Earnings Summary - TradingView
INSPIREMD Earnings Results: $NSPR Reports Quarterly Earnings - Nasdaq
InspireMD Inc. (NSPR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.93%
자본화:
|
볼륨(24시간):